SpaceX’s stock falls as Wall Street gets spooked by the extent of AI spending

SpaceX shares fell as Wall Street focused on the scale of AI investment, with Morgan Stanley expecting $64B in total capital spending this year. Despite a 247% year-over-year jump in second-quarter AI revenue and slightly lower operating losses, investors remain cautious about the heavy cash burn required to execute. The company also reported positive adjusted EBITDA for the first time in that business segment.

Analysis

The market is reacting less to one company’s spending and more to a potential regime shift: AI is moving from “growth-at-any-cost” toward “prove the payback.” That is usually bearish for the highest-duration parts of the AI complex because multiples start to key off free cash flow timing instead of TAM narratives. It is mildly supportive for the strongest platforms that can self-fund capex, but only if their revenue curve keeps outrunning spend.

For MS, the direct earnings impact is negligible; this is a sentiment read-through, not a fundamental banking event. The only plausible second-order channel is slower private-market enthusiasm for late-stage AI stories, which could modestly reduce advisory/financing velocity over the next 1-2 quarters. That’s not enough to make MS a stand-alone trade, but it does argue against treating it as an AI-levered winner.

The contrarian point is that the spend itself may be rational if it is buying scarce compute, data, or distribution moats; a 247% revenue ramp with improving EBITDA suggests the business is still in investment mode, not stress mode. The thesis is falsified if upcoming hyperscaler guidance shows capex discipline without a matching slowdown in AI product growth, or if AI revenue decelerates while spending stays elevated; that would justify a sharper de-rating in AI hardware and systems names.

Key Decisions for Investors

• No immediate trade in MS; treat this as a sentiment-only headline and avoid forcing a position for the next 1-2 weeks.
• If the AI complex sells off on capex fear, buy MSFT / short SMCI as a 1-3 month quality-vs-beta pair; risk is a fresh wave of order acceleration that re-lifts high-beta suppliers.
• Use any broad AI rally to trim the most valuation-stretched capex beneficiaries (SMCI, ANET) and rotate toward cash-generative platforms like MSFT or GOOGL over a 1-3 month horizon.
• Set an alert for next hyperscaler capex guides and AI revenue commentary; if capex remains elevated and monetization holds, cover any short AI-infra exposure quickly.
• Do not short NVDA on this headline alone; if anything, it remains the cleaner long vs. systems integrators because it has the strongest pricing power and least balance-sheet risk.